MRSA is an antimicrobial resistance (AMR) superbug that causes over 120,000 deaths per year. Given the urgent need for new, more effective antibiotics and a lack of MRSA vaccines, understanding ...

As mentioned earlier, there is an urgent need for the development of novel antibiotics targeting S. aureus. Fortunately, a number of new agents active against MRSA and other Gram-positive ...

Recent worldwide emergence of CA-MRSA has prompted the development of several new antibiotics (see Table 2). In the past, as vancomycin became less effective against MRSA, clinicians turned to ...

Antibiotic treatment during an influenza infection actually impaired the body’s efforts to clear bacteria rather than helping the body heal.

MRSA is a type of staph highly resistant to a common class of antibiotics. Many people carry MRSA harmlessly on their skin or inside their noses. However, if the bacteria penetrates the skin ...

The people were treated with two or more days of anti–methicillin-resistant Staphylococcus aureus (MRSA) or anti-pseudomonal antibiotics, but didn’t have resistant organisms requiring the ...

The US accounts for 80% to 90% of the total market for anti-MRSA antibiotics, so FDA approval is key to growing ceftobiprole's revenues, currently a minor part of its CHF 131 million ($137 million ...

Public health officials are concerned that we could move back into a situation like that of the early 20th century, before ...

Many patients presenting to the emergency room with skin and soft tissue infections were found to be having MRSA infection that was resistant to traditional antibiotics, such as cephalexin and ...

This marks Zevtera as the sole FDA-approved MRSA-targeting cephalosporin antibiotic for these conditions. It is also indicated for acute bacterial skin and skin structure infections (ABSSSI ...